Marksans Pharma Limited

Marksans Pharma Limited financial statements

Marksans Pharma Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2026

RevenueINR 29.51BEODHD
Net incomeINR 4.18BEODHD
Cash and equivalentsINR 6.34BEODHD
Total debtINR 3.43BEODHD

Marksans Pharma Limited financials on 6ix · Marksans Pharma Limited on 6ix